Actinium Pharmaceuticals
ATNM
#9671
Rank
S$54.97 M
Marketcap
$1.76
Share price
-7.14%
Change (1 day)
-75.24%
Change (1 year)

Earnings for Actinium Pharmaceuticals (ATNM)

Earnings in 2024 (TTM): -S$59.6 Million

According to Actinium Pharmaceuticals's latest financial reports the company's current earnings are S$0.08 Million. In 2023 the company made an earning of -S$70.39 Million a decrease over its 2022 earnings that were of -S$46.24 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Actinium Pharmaceuticals from 2007 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$59.6 Million-15.34%
2023 -S$70.39 Million52.24%
2022 -S$46.24 Million36.61%
2021 -S$33.85 Million11.48%
2020 -S$30.36 Million1.46%
2019 -S$29.92 Million-7.37%
2018 -S$32.31 Million-11.46%
2017 -S$36.49 Million10.67%
2016 -S$32.97 Million15.7%
2015 -S$28.5 Million-14.86%
2014 -S$33.47 Million129.19%
2013 -S$14.61 Million-8.55%
2012 -S$15.97 Million
2010 S$0.01 M-152.15%
2009 -S$0.03 Million-39.8%
2008 -S$0.04 Million120.29%
2007 -S$0.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$50.42 Million-17.28%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.53 B-970.68%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$92.66 Million 52.03%๐Ÿ‡บ๐Ÿ‡ธ USA